Formule B-1
Natural health product licensed in Canada
- Other names
- Laxatif stimulant
- Licence holder
- Les Herbages Normex Ltée
- NPN or DIN-HM
- 80123468
- Status
- Active licence
- Licence date
- 9 March 2023
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bos taurus | 65 mg | Not calculated |
| Pancréatine Potency : 3,000 USP PU Protéase | Not specified | Not calculated |
| Pancréatine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 120 mg Potency : 240 Unité d'activité lipase de la USP Triacylglycérol lipase | 30 mg | Not calculated |
| Pancréatine Potency : 3,000 Unité d'activité protéase de la USP alpha-amylase | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
(Utilisé traditionnellement en phytothérapie comme) laxatif stimulant pour faciliter l'évacuation intestinale et le soulagement à court-terme de la constipation occasionnelle.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Cesser l'utilisation et consulter un praticien de soins de santé/fournisseur de soins de santé/professionnel de la santé/docteur/médecin si de la nausée, des vomissements, de la douleur abdominale/épigastrique et des brûlements gastriques se manifestent. Cesser l'utilisation si une hypersensibilité/allergie se manifeste.
Source
Official Health Canada record, licence 80123468
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.